Concepedia

Bindu George

BG

Statistics

Publications

7

Citations

609

H-Index

7

Active since

1994

Affiliations

United States Food and Drug Administration(Current)

Center for Biologics Evaluation and Research

Center for Drug Evaluation and Research

Bindu George is an author at United States Food and Drug Administration specializing in health sciences, medicine, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1994–2024

7

Publications

7

FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia

Maura O’Leary, Xiaobin Lü, Ying Huang et al. · Clinical Cancer Research · 2018 · 273 citations · Full text

FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma

Najat Bouchkouj, Yvette L. Kasamon, R. Angelo de Claro et al. · Clinical Cancer Research · 2018 · 220 citations

FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma

Kavita Natrajan, Megha Kaushal, Bindu George et al. · Clinical Cancer Research · 2024 · 35 citations · Full text

, , +18

Oblique Transcorporeal Drilling to Treat Anterior Compression of the Spinal Cord at the Cervical Level

Bindu George, G. Lot · min - Minimally Invasive Neurosurgery · 1994 · 28 citations

, , +15

FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma

Najat Bouchkouj, Megan Zimmerman, Yvette L. Kasamon et al. · The Oncologist · 2022 · 26 citations · Full text

, , +18

1–5 of 7